Medical and Patient Educational videos

Highlighted talk:

Full presentation Chronic pulmonary aspergillosis, by Prof David Denning. Presented in March 2016.

Also see our Aspergillus & Aspergillosis Youtube Channel

Displaying 151 - 175 of 261
Awareness
Open the windows Poetry & Medicine

Literary event - Manchester Literature Festival hosted at Manchester Museum to increase awareness of Aspergillosis, in October 2013. Exploring literature, music and medicine.

Antifungal drugs
The Role of Echinocandins

Fungi are eukaryotic organisms which possess a unique cell wall and cell membrane that can serve as targets for antifungal agents. The echinocandin class of antifungal agents target the cell wall of fungi.

The Role of Amphotericin

Fungi are eukaryotic organisms which possess a unique cell wall and cell membrane that can serve as targets for antifungal agents. Polyene antifungal agents such as Amphotericin B target the fungal cell membrane.

Antifungals (Fungal Infections - Lesson 4)

A review of antifungals, focusing on amphotericin B, azoles, and echinocandins. Structure, mechanism, spectrum of antifungal activity, common clinical uses, and common side effects/toxicities are all discussed. (April 2015)

The Role of Amphotericin

Fungi are eukaryotic organisms which possess a unique cell wall and cell membrane that can serve as targets for antifungal agents. Polyene antifungal agents such as Amphotericin B target the fungal cell membrane.

The Role of Azoles

Fungi are eukaryotic organisms which possess a unique cell wall and cell membrane that can serve as targets for antifungal agents. Polyene antifungal agents such as Amphotericin B target the fungal cell membrane. 

Research & Science
Overview of Fungal Cell Structure

Fungi are eukaryotic organisms and are not related to bacteria. As eukaryotes, they contain membrane bound organelles and possess a cell membrane surrounded by a rigid cell wall.

Indoor Air & Pollution
Sloan Symposium Conference Workshop

Healthy Buildings 2015 Europe - Eindhoven, The Netherlands

Mark Hernandez "Optical Particle Recogntion for (Practical) Discrimination Between Bioaerosol Classes"

Healthy Buildings 2015 Europe - Eindhoven, The Netherlands

Martin Täubel "Quantitative PCR in Microbial Assessment of Indoor Spaces"

Healthy Buildings 2015 Europe - Eindhoven, The Netherlands

Tiina Reponen "Main Principles for Bioaerosol Sampling and Analysis"

Healthy Buildings 2015 Europe - Eindhoven, The Netherlands

Maria Nunez "Microbial Sampling in Building Surveys - What and Why are We Sampling"

Healthy Buildings 2015 Europe - Eindhoven, The Netherlands

Kristian F. Nielsen "Microbila Growth and Interactions on Indoor Surfaces - Microbila Secondary Metabolites and Mycotoxins"

Healthy Buildings 2015 Europe - Eindhoven, The Netherlands

Anne Hyvärinen "Assessment of Moisture and Mold Problems - the Finnish Example"

Healthy Buildings 2015 Europe - Eindhoven, The Netherlands

Jeffrey Siegel "Moisture and the Indoor Microbiome"

Healthy Buildings 2015 Europe - Eindhoven, The Netherlands

Jordan Peccia "Revolution/Evolution - DNA Sequencing To Identify Indoor Air Microorganisms"

Healthy Building 2015, Eindhoven, The Netherlands

Miia Pitkäranta "Molecular Tools & Microbial Ecology of Buildings - A Practitioner's View"

From Healthy Buildings 2015, Eindhoven, The Netherlands

Patients experiences
Stewart Armstrong: A personal account on discovering that he has aspergillosis

Stewart Armstrong is an aspergillosis patient. A very fit young man he has opted to launch his own campaign to raise awareness and fundraise for Aspergillosis Research.

General interest
Bridging the Health Divide in Europe

European Respiratory Society: The current difficult econominc and financial environment is causing significant differences in the treatment of resiratory disease across europe.

Translational Medicine in Respiratory Disease

European Respiratory Society: Speeding up the development of new treatment by removing barriers to progress.

ERS Vision - Personalising Respiratory Care in Europe

European Respiratory Society: Personalised medication and telehealth are transforming the way disease is prevented, treated and managed.

Nutritional Science in the Prevention & Management of COPD

European Respiratory Society: Current thinking regarding the importance of nutritional science in the management and prevention of COPD.

Designing Drugs to Better Help Real Lives

European Respiratory Society: Should we be testing new drugs in the 'real' world where some patients smoke, are obese and have other comorbidities? 

The Lung Health Research & Medicine Revolution

European Respiratory Society: A revolutionary collaborative approach to research funding is providing new insights into the origins of chronic respiratory diseases.

Clean Air and Lung Health

European Respiratory Society: Clean air is vitally important for people who live with aspergillosis.

Pages